论文部分内容阅读
目的:探究胺碘酮和美托洛尔治疗慢性心功能不全合并室性心律失常的临床疗效。方法:选取2014年1月-2014年12月我院收治的54例慢性心功能不全合并室性心律失常的患者为研究对象,将其随机分为对照组和治疗组,每组27例患者。对照组采用单一的胺碘酮进行治疗,治疗组采用胺碘酮联合美托洛尔进行治疗,对临床治疗效果进行分析。结果:在本次研究中,治疗组治疗有效的人数有23例,治疗总有效率为85.1%,对照组治疗有效人数有19例,治疗总有效率为70.1%,两组治疗效果差异性显著,具有统计学意义(P<0.05)。结论:对慢性心功能不全合并室性心律失常患者采用胺碘酮和美托洛尔进行治疗,其效果明确,用药安全性比较高,因此值得临床推广和应用。
Objective: To investigate the clinical efficacy of amiodarone and metoprolol in the treatment of ventricular arrhythmias in patients with chronic heart failure. Methods: From January 2014 to December 2014, 54 cases of patients with chronic cardiac dysfunction and ventricular arrhythmia admitted to our hospital were selected as study subjects and randomly divided into control group and treatment group with 27 patients in each group. The control group was treated with single amiodarone. The treatment group was treated with amiodarone and metoprolol, and the clinical effect was analyzed. Results: In this study, the treatment group, the number of effective treatment of 23 cases, the total effective rate was 85.1%, the control group, the effective number of treatment was 19 cases, the total effective rate was 70.1%, the two groups were significantly different therapeutic effect , With statistical significance (P <0.05). Conclusion: The treatment of amiodarone and metoprolol in patients with chronic cardiac insufficiency complicated with ventricular arrhythmias has a clear effect and high safety of medication. Therefore, it is worthy of clinical promotion and application.